Early Administration of Norepinephrine in Sepsis

PHASE4RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

August 31, 2025

Conditions
Sepsis, Severe
Interventions
DRUG

Norepinephrine Bitartrate

"The NE will be prepared as follows: 4 mg mixed with 250 ml of 5% glucose resulting in a final norepinephrine concentration of 0.016 mg/ml. For the control group placebo: 250 ml of 5% glucose will be prepared.~Both drugs will be infused via a peripheral line or a venous catheter. The intravenous infusion rate varies from 8 to 15 ml/hour, adjusted according to body weight to obtain norepinephrine at 0.05 microgram/kg/min (ie 0.128 to 0.24 mg per hour) in continuous infusion."

OTHER

Placebo

For the control group placebo: 250 ml of 5% glucose will be prepared and will be infused via a peripheral line or a venous catheter. The intravenous infusion rate varies from 8 to 15 ml/hour.

Trial Locations (1)

1007

RECRUITING

intensive care unit of the University Hospital Center La Rabta, Tunis

All Listed Sponsors
lead

Tunis University

OTHER